Rabbit endogenous retrovirus-H encodes a functional protease

Journal of General Virology

Volumn 84, Issue 1, 2003, Pages 215-225

  Voisset, Cécile ^a   Myers, Richard E ^a   Carne, Alex ^b,c   Kellam, Paul ^a   Griffiths, David J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC PROTEINASE; BACTERIAL ENZYME; DNA; GAG PROTEIN; PEPSTATIN; POLYPROTEIN; PROTEIN PRECURSOR; PROTEINASE; VIRUS ENZYME;

AMINO TERMINAL SEQUENCE; AVIAN MYELOBLASTOSIS VIRUS; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENDOGENOUS VIRUS; ENZYME INHIBITION; ENZYME STRUCTURE; GENE AMPLIFICATION; GENETIC CODE; IN VITRO STUDY; MASON PFIZER MONKEY VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RABBIT; RETROVIRUS; REVIEW; SEQUENCE ANALYSIS; VIRUS GENOME;

AVES; AVIAN MYELOBLASTOSIS ASSOCIATED VIRUS; AVIAN MYELOBLASTOSIS VIRUS; BACTERIA (MICROORGANISMS); MASON-PFIZER MONKEY VIRUS; ORYCTOLAGUS CUNICULUS; RABBIT ENDOGENOUS RETROVIRUS H; RNA VIRUSES; UNIDENTIFIED RETROVIRUS;

EID: 0037234277     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.18670-0     Document Type: Review

References (51)

1. Berman, H. M., Westbrook J., Feng, Z., Gilliland, G., Bhat, T. N., Weissig, H., Shindyalov, I. N. & Bourne, P. E. (2000). The Protein Data Bank. Nucleic Acids Res 28, 235-242.
2. Bianchi, M., Bolgegrain, R. A., Castro, B. & Coletti-Previero, M. A. (1990). N-terminal domain of pepsin as a model for retroviral dimeric aspartyl protease. Biochem Biophys Res Commun 167, 339-344.
3. Brand, A., Griffiths, D. J., Herve, C., Mallon, E. & Venables, P. J. (1999). Human retrovirus-5 in rheumatic disease. J Autoimmun 13, 149-154.
4. Darke, P. L., Leu, C. T., Davis, L. J., Heimbach, J. C., Diehl, R. E., Hill, W. S., Dixon, R. A. & Sigal, I. S. (1989). Human immunodeficiency virus protease. Bacterial expression and characterization of the purified aspartic protease. J Biol Chem 264, 2307-2312.
5. Davies, D. R. (1990). The structure and function of the aspartic proteinases. Annu Rev Biophys Biomol Struct 19, 189-215.
6. Dean, C. J., Gyure, L. A., Hall, J. G. & Styles, J. M. (1986). Production of IgA-secreting rat X rat hybridomas. Methods Enzymol 121, 52-59.
7. Debouck, C., Gorniak J. G., Strickler, J. E., Meek T. D., Metcalf, B. W. & Rosenberg, M. (1987). Human immunodeficiency virus protease expressed in Escherichia coli exhibits autoprocessing and specific maturation of the Gag precursor. Proc Natl Acad Sci U S A 84, 8903-8906.
8. Dreyer, G. B., Metcalf, B. W., Tomaszek, T. A., Jr & 9 other authors (1989). Inhibition of human immunodeficiency virus 1 protease in vitro: rational design of substrate analogue inhibitors. Proc Natl Acad Sci U S A 86, 9752-9756.
9. Elder, J. H., Lerner, D. L., Hasselkus-Light, C. S., Fontenot D. J., Hunter, E., Luciw, P. A., Montelaro, R. C. & Phillips, T. R. (1992). Distinct subsets of retroviruses encode dUTPase. J Virol 66, 1791-1794.
10. Evan, G. I., Lewis, G. K., Ramsay, G. & Bishop, J. M. (1985). Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol Cell Biol 5, 3610-3616.
11. Graves, M. C., Lim, J. J., Heimer, E. P. & Kramer, R. A. (1988). An 11-kDa form of human immunodeficiency virus protease expressed in Escherichia coli is sufficient for enzymatic activity. Proc Natl Acad Sci U S A 85, 2449-2453.
12. Griffiths, D. J. (1996). Investigation of a novel retroviral element isolated from human salivary gland. PhD thesis. University of London, London, UK.
13. Griffiths, D. J., Venables, P. J., Weiss, R. A. & Boyd, M. T. (1997). A novel exogenous retrovirus sequence identified in humans. J Virol 71, 2866-2872.
14. Griffiths, D. J., Cooke, S. P., Herve, C. & 11 other authors (1999). Detection of human retrovirus 5 in patients with arthritis and systemic lupus erythematosus. Arthritis Rheum 42, 448-454.
15. Griffiths, D. J., Voisset, C., Venables, P. J. W. & Weiss, R. A. (2002). Novel endogenous retrovirus of rabbits previously identified as human retrovirus 5. J Virol 76, 7094-7102.
16. Grinde, B., Cameron, C. E., Leis, J., Weber, I. T., Wlodawer, A., Burstein, H. & Skalka, A. M. (1992). Analysis of substrate interactions of the Rous sarcoma virus wild type and mutant proteases and human immunodeficiency virus-1 protease using a set of systematically altered peptide substrates. J Biol Chem 267, 9491-9498.
17. Gustchina, A., Kervinen, J., Powell, D. J., Zdanov, A., Kay, J. & Wlodawer, A. (1996). Structure of equine infectious anemia virus proteinase complexed with an inhibitor. Protein Sci 5, 1453-1465.
18. Hansen, J., Billich, S., Schulze, T., Sukrow, S. & Moelling, K. (1988). Partial purification and substrate analysis of bacterially expressed HIV protease by means of monoclonal antibody. EMBO J 7, 1785-1791.
19. Hatfield, D. L., Levin, J. G., Rein, A. & Oroszlan, S. (1992). Translational suppression in retroviral gene expression. Adv Virus Res 41, 193-239.
20. Hayakawa, T., Misumi, Y., Kobayashi, M., Yamamoto, Y. & Fujisawa, Y. (1992). Requirement of N- and C-terminal regions for enzymatic activity of human T-cell leukemia virus type I protease. Eur J Biochem 206, 919-925.
21. Hill, J. & Phylip, L. H. (1997). Bacterial aspartic proteinases. FEBS Lett 409, 357-360.
22. Hoog, S. S., Towler, E. M., Zhao, B., Doyle, M. L., Debouck C. & Abdel-Meguid, S. S. (1996). Human immunodeficiency virus protease ligand specificity conferred by residues outside of the active site cavity. Biochemistry 35, 10279-10286.
23. Hruskova-Heldingsfeldova, O., Andreansky, M., Fabry, M., Blaha, I., Strop, P. & Hunter, E. (1995). Cloning, bacterial expression, and characterization of the Mason-Pfizer monkey virus proteinase. J Biol Chem 270, 15053-15058.
24. Katoh, I., Yoshinaka, Y., Rein, A., Shibuya, M., Odaka, T. & Oroszlan, S. (1985). Murine leukemia virus maturation: protease region required for conversion from 'immature' to 'mature' core form and for virus infectivity. Virology 145, 280-292.
25. Katoh, I., Yasunaga, T., Ikawa, Y. & Yoshinaka, Y. (1987). Inhibition of retroviral protease activity by an aspartyl proteinase inhibitor. Nature 329, 654-656.
26. Kervinen, J., Lubkowski, J., Zdanov, A. & 7 other authors (1998). Toward a universal inhibitor of retroviral proteases: comparative analysis of the interactions of LP-130 complexed with proteases from HIV-1, FIV, and, EIAV. Protein Sci 7, 2314-2323.
27. Kohl, N. E., Emini, E. A., Schieif, W. A., Davis, L. J., Heimbach, J. C., Dixon, R. A., Scolnick, E. M. & Sigal, I. S. (1988). Active human immunodeficiency virus protease is required for viral infectivity. Proc Natl Acad Sci U S A 85, 4686-4690.
28. Kozireva, S., Lejniece, S., Blomberg, J. & Murovska, M. (2001). Human retrovirus type 5 sequences in non-Hodgkin's lymphoma of T cell origin. AIDS Res Hum Retroviruses 17, 953-956.
29. Krohn, A., Redshaw, S., Ritchie, J. C., Graves, B. J. & Hatada, M. H. (1991). Novel binding mode of highly potent HIV-proteinase inhibitors incorporating the (R)-hydroxyethylamine isostere. J Med Chem 34, 3340-3342.
30. Leuthardt, A. & Roesel, J. L. (1993). Cloning, expression and purification of a recombinant poly-histidine-linked HIV-1 protease. FEBS Lett 326, 275-280.
31. Miller, M., Jaskolski, M., Rao, J. K., Leis, J. & Wlodawer, A., (1989). Crystal structure of a retroviral protease proves relationship to aspartic protease family. Nature 337, 576-579.
32. Mueller-Lantzsch, N., Sauter, M., Weiskircher, A., Kramer, K., Best, B., Buck, M. & Grasser, F. (1993). Human endogenous retroviral element K10 (HERV-K10) encodes a full-length gag homologous 73-kDa protein and a functional protease. AIDS Res Hum Retroviruses 9, 343-350.
33. Murovska, M., Lejniece, S., Kozireva, S., Koulikovska, M., Yin, H. & Blomberg, J. (2000). Human retrovirus 5 sequences in peripheral blood cells of patients with B-cell non-Hodgkin's lymphoma. Int J Cancer 85, 762-770.
34. Nam, S. H. & Hatanaka, M. (1986). Identification of a protease gene of human T-cell leukemia virus type I (HTLV-I) and its structural comparison. Biochem Biophys Res Commun 139, 129-135.
35. Orengo, C. A. (1999). CORA - topological fingerprints for protein structural families. Protein Sci 8, 699-715.
36. Pichova, I., Strop, P., Sedlacek, J. & 7 other authors (1992). Isolation, biochemical characterization and crystallization of the p15gag proteinase of myeloblastosis associated virus expressed in E. coli. Int J Biochem 24, 235-242.
37. Rao, J. K, Erickson, J. W. & Wlodawer, A. (1991). Structural and evolutionary relationships between retroviral and eucaryotic aspartic proteinases. Biochemistry 30, 4663-4671.
38. Ratner, L., Haseltine, W., Patarca, R. & 7 other authors (1985). Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature 313, 277-284.
39. Rigby, S. P., Griffiths, D. J., Jarrett, R. F., Weiss, R. A. & Venables, P. J. (1998). A new human retrovirus: a role in lymphoma? Am J Med 104, 99-100.
40. Sali, A. & Blundell, T. L. (1993). Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 234, 779-815.
41. Sambrook J. E, Fritsch, F. & Maniatis, T. (1989). Molecular Cloning. a Laboratory Manual, 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
42. Sellos-Moura, M. & Vogt, V. M. (1996). Proteolytic activity of purified avian sarcoma and leukemia virus NC-PR protein expressed in Escherichia coli. Virology 221, 335-345.
43. Sommerfelt M. A., Petteway, S. R., Jr, Dreyer, G. B. & Hunter, E. (1992). Effect of retroviral proteinase inhibitors on Mason-Pfizer monkey virus maturation and transmembrane glycoprotein cleavage. J Virol 66, 4220-4227.
44. Stříšovský, K., Smrz, D., Fehrmann, F., Krausslich, H. G. & Konvalinka, J. (2002). The murine endogenous retrovirus MIA14 encodes an active aspartic proteinase that is functionally similar to proteinases from D-type retroviruses. Arch Biochem Biophys 398, 261-268.
45. Umezawa, H., Aoyagi, T., Morishima, H., Matsuzaki, M. & Hamada, M. (1970). Pepstatin, a new pepsin inhibitor produced by actinomycetes. J Antibiot (Tokyo) 23, 259-262.
46. Vogt V. M., Wight A. & Eisenman, R. (1979). In vitro cleavage of avian retrovirus Gag proteins by viral protease p15. Virology 98, 154-167.
47. Wan, M., Takagi, M., Loh, B. N., Xu, X. Z. & Imanaka, T. (1996). Autoprocessing: an essential step for the activation of HIV-1 protease. Biochem J 316, 569-573.
48. Wlodawer, A. & Gustchina, A. (2000). Structural and biochemical studies of retroviral proteases. Biochim Biophys Acta 1477, 16-34.
49. Wlodawer, A., Miller, M., Jaskolski, M. & 7 other authors (1989). Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease. Science 245, 616-621.
50. Wu, J., Adomat, J. M., Ridky, T. W., Louis, J. M., Leis, J., Harrison, R. W. & Weber, I. T. (1998). Structural basis for specificity of retroviral proteases. Biochemistry 37, 4518-4526.
51. Zhang, Z. Y., Poorman, R. A., Maggiora, L. L., Heinrikson, R. L. & Kezdy, F. J. (1991). Dissociative inhibition of dimeric enzymes. Kinetic characterization of the inhibition of HIV-1 protease by its COOH-terminal tetrapeptide. J Biol Chem 266, 15591-15594.